Abstract
Advancements in the management of congestive heart failure (CHF) have led to continuous-flow left ventricular assist devices (CF-LVAD). CHF patients tend to have hepatic congestion and impaired hepatic synthetic function. These lead to coagulation abnormalities and may contribute to peri-operative bleeding; vitamin K administered pre-operatively may attenuate this phenomenon. The aim of this study was to understand the role of pre operative vitamin K on transfusion requirements post implant.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
